Topics

Harvest Health & Recreation, Inc. Reports Second Quarter 2019 Financial Results

07:00 EDT 15 Aug 2019 | Businesswire
Harvest Health & Recreation, Inc.
  • Total revenue for the second quarter was $26.6 million, up 39% from the first quarter 2019 (all dollars are U.S. dollars)
  • Adjusted EBITDA for the second quarter totaled ($2.2) million

Harvest Health & Recreation, Inc. (CSE: HARV, OTCQX: HRVSF), vertically-integrated cannabis company with one of the largest and deepest footprints in the U.S., today reported the company’s second quarter fiscal year 2019 financial results. Harvest has continued to be successful in winning licenses in non-competitive and competitive application processes throughout the country and has announced several significant strategic acquisitions and mergers. Harvest’s ability to combine size, scale, capital, regulatory expertise and operational excellence are paramount to its success.

“During the second quarter, Harvest continued to execute on its strategy by adhering to our four core initiatives: building a world class team, expanding our retail and wholesale footprint across the U.S., building and acquiring brands and distributing them across our footprint and continuing on a path of profitable growth we believe that we can fulfill our objective of becoming the most valuable cannabis company in the world,” said Chief Executive Officer Steve White.

Financial Highlights for the Second Quarter Ended June 30, 2019

  • Total revenue was $26.6 million, an increase of 39%, compared to $19.2 million in the first quarter of 2019.
  • On a pro forma basis, Harvest along with completed and pending disclosed acquisitions, generated $78 million of revenue in the second quarter, or over $310 million annualized. Second quarter pro forma revenue increased 53% over first quarter pro forma revenue of $51 million.
  • Gross profit was $16.9 million compared to $7.9 million in the first quarter of 2019.
  • Gross profit margin was 64% compared to 41% for the first quarter of 2019.
  • Adjusted EBITDA was ($2.2) million, compared to ($4.7) million in the first quarter of 2019.
  • Net loss was $20.6 million for the second quarter which is reflective of the planned investments in people and infrastructure to support the company’s growth initiatives and planned expansion.

Business Highlights

Footprint Expansion

As of June 30, 2019, the Company operated 16 retail locations compared to 13 retail locations at the end of March 31, 2019. During the quarter, the Company announced the pending acquisition of Cannapharmacy, the award of a retail dispensary license in Pasadena, CA, and opened three additional retail locations in Florida. Subsequent to quarter end, the Company added six retail locations in Arizona, California, Florida, and North Dakota and was one of eight companies selected to move forward to finalize a cultivation license in Utah. Significant expansion of cultivation, manufacturing and retail locations is expected to occur for the remainder of 2019.

Brand and Product Distribution

During the second quarter, the Company announced an agreement with the Asian American Trade Associations Council to distribute Colors, CBx Essentials, and Harvest branded CBD product lines to more than 10,000 retail locations within the AATAC retailer network.

Financing Activities

  • During the quarter Harvest closed on an initial $100 million tranche of an available $500 million of convertible debentures. The debentures are issuable, at Harvest’s sole discretion, in tranches of $100 million and have a 7% interest rate. The initial tranche of debentures will be convertible at the option of the holder to Subordinate Voting Shares of Harvest at a price of $11.42 per Subordinate Voting Share.
  • Subsequent to quarter end, the Company announced the signing of a term sheet for a secured term loan for up to $225 million from an investment fund managed by Torian Capital. The expected loan will be made available to Harvest in three tranches of $75 million, each with substantially identical terms. The loan will be secured by certain current and future assets of Harvest, including cannabis related licenses.

As of June 30, 2019, the Company had $89.9 million of cash and cash equivalents.
As of June 30, 2019, the Company had $105.1 million of debt outstanding.

Team Growth

  • During the second quarter, Harvest significantly added to its management team, including the hiring of: Nicole Stanton, General Counsel; Allyson Wilcox, Assistant General Counsel, Alex Howe, Head of Corporate Communications and Christine Hersey as Director of Investor Relations. Nicole Stanton has over 20 years’ experience and was the first female to lead a national law firm in Phoenix with leadership roles in the community as founder of Stop Bullying AZ and First Lady of Phoenix. Allyson Wilcox has over 15 years’ experience as an attorney and has taken a leadership role at Harvest leading the Regulatory Compliance and Licensing Departments. Alex Howe has nearly two decades experience in corporate communications with Fortune 50, corporate, tech, consumer, and cannabis companies and leads the company’s external and internal communications. Christine Hersey has over 15 years’ experience as a buy side and sell side analyst covering high growth and complex sectors.
  • Subsequent to quarter end, Harvest welcomed Michael Aguirre as Assistant General Counsel. Michael Aguirre has 14 years’ experience serving companies across a wide range of industries and adds M&A and financing capabilities to the growing legal team.
  • Harvest continues to build out its team, ending Q2 with 782 FTEs, up from 476 FTEs at the end of Q1 2019.

Please see the supplemental information (unaudited) regarding Non-IFRS Financial Measures at the end of this press release.

Conference Call & Webcast

Harvest Health and Recreation, Inc. will host a conference call and audio webcast with Chief Executive Officer Steve White, President Steve Gutterman and Chief Financial Officer Leo Jaschke, Thursday August 15th at 8:00am ET.

To participate in the conference call, please dial:

US toll free: + 1-844-695-5522
Canada toll free: + 1-866-605-3852
UK toll free: + 08082389064
International dial in: + 1-412-317-5448

Registration is required; please plan to dial in at least ten minutes prior to the scheduled start time.

Second quarter results will be available at:
https://www.harvestinc.com/investors/investors/#financial-information

The conference call will be available for replay for three months at:
https://services.choruscall.com/links/harv190815.html

HARVEST HEALTH & RECREATION INC.

Interim Unaudited Condensed Consolidated Statements of Operations

Three and Six Months Ended June 30, 2019 and 2018

(Amounts expressed in thousands of United States dollars, except share or per share data)

 
 

 

For the three months ended
June 30,

 

For the six months ended
June 30,

 

 

2019

 

2018

 

2019

 

2018

 

Revenue

$

26,596

 

$

10,524

 

$

45,836

 

$

18,859

 

Cost of goods sold

 

(19,915

)

 

(3,059

)

 

(31,250

)

 

(7,077

)

Gross profit, before biological asset adjustments

 

6,681

 

 

7,465

 

 

14,586

 

 

11,782

 

Unrealized gain on changes in fair value of biological asset

 

17,969

 

 

2,133

 

 

23,741

 

 

2,133

 

Cost of goods sold on biological asset transformation

 

(7,740

)

 

(3,929

)

 

(13,475

)

 

(3,559

)

Gross profit

 

16,910

 

 

5,669

 

 

24,852

 

 

10,356

 

Expenses

 

 

 

 

 

 

 

 

 

 

 

 

General and administrative

 

21,764

 

 

3,218

 

 

40,150

 

 

5,786

 

Sales and marketing

 

2,053

 

 

234

 

 

3,642

 

 

437

 

Share-based compensation expense

 

8,094

 

 

 

 

11,397

 

 

 

Depreciation and amortization

 

1,600

 

 

359

 

 

3,093

 

 

736

 

Total expenses

 

33,511

 

 

3,811

 

 

58,282

 

 

6,959

 

Operating (loss) income

 

(16,601

)

 

1,858

 

 

(33,430

)

 

3,397

 

Other (expense) income

 

 

 

 

 

 

 

 

 

 

 

 

Gain on sale of assets and impairment, net

 

90

 

 

1,526

 

 

90

 

 

1,526

 

Other (loss) income

 

(200

)

 

 

 

(249

)

 

 

Foreign currency (loss) gain

 

(403

)

 

 

 

(778

)

 

 

Interest expense

 

(2,439

)

 

(185

)

 

(3,214

)

 

(305

)

(Loss) income before taxes and non-controlling interest

 

(19,553

)

 

3,199

 

 

(37,581

)

 

4,618

 

Income taxes

 

(1,637

)

 

(812

)

 

(4,035

)

 

(1,420

)

(Loss) income before non-controlling interest

 

(21,190

)

 

2,387

 

 

(41,616

)

 

3,198

 

Loss (income) attributed to non-controlling interest

 

590

 

 

443

 

 

968

 

 

878

 

Net (loss) income attributed to Harvest Health & Recreation Inc.

 

(20,600

)

 

2,830

 

 

(40,648

)

 

4,076

 

(Loss) income per share - basic and diluted

$

(0.07

)

 

 

 

$

(0.14

)

 

 

 

Attributable to Harvest Health and Recreation Inc. Stockholders

$

(0.07

)

 

 

 

$

(0.15

)

 

 

 

Attributable to non-controlling interest

$

0.00

 

 

 

 

$

0.00

 

 

 

 

Weighted-average shares outstanding - basic and diluted

 

285,071,254

 

 

 

 

 

284,690,893

 

 

 

 

HARVEST HEALTH & RECREATION INC.

Interim Unaudited Condensed Consolidated Statements of Financial Position

June 30, 2019 and 2018

(Amounts expressed in thousands of United States dollars)

 
 

 

June 30,
2019

 

December 31,
2018

 

ASSETS

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

Cash and cash equivalents

$

89,913

 

$

191,883

 

Restricted cash

 

8,000

 

 

8,000

 

Accounts receivable, net

 

8,759

 

 

2,993

 

Notes receivable, current portion

 

34,539

 

 

13,600

 

Biological assets

 

9,869

 

 

6,788

 

Inventory

 

39,046

 

 

23,177

 

Other current assets

 

5,252

 

 

1,810

 

Total current assets

 

195,378

 

 

248,251

 

Notes receivable, net of current portion

 

18,598

 

 

3,076

 

Property, plant and equipment, net

 

121,356

 

 

31,855

 

Right-of-use asset, net

 

39,260

 

 

 

Intangibles assets, net

 

131,068

 

 

112,830

 

Corporate investments

 

5,000

 

 

5,000

 

Acquisition deposits

 

5,416

 

 

1,350

 

Goodwill

 

73,836

 

 

69,407

 

Other assets

 

8,149

 

 

6,830

 

TOTAL ASSETS

$

598,061

 

$

478,599

 

LIABILITIES AND STOCKHOLDERS' EQUITY

 

 

 

 

 

 

LIABILITIES

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

Accounts payable

$

7,337

 

$

4,694

 

Other current liabilities

 

12,696

 

 

6,715

 

Contingent consideration, current portion

 

11,188

 

 

11,520

 

Income tax payable

 

5,084

 

 

4,120

 

Lease liability, current portion

 

2,220

 

 

 

Notes payable, current portion

 

7,013

 

 

11,806

 

Total current liabilities

 

45,538

 

 

38,855

 

Notes payable, net of current portion

 

98,079

 

 

19,098

 

Lease liability, net of current portion

 

38,763

 

 

 

Deferred tax liability

 

20,028

 

 

18,173

 

Contingent consideration, net of current portion

 

18,245

 

 

18,190

 

Other long-term liabilities

 

250

 

 

4,486

 

TOTAL LIABILITIES

 

220,903

 

 

98,802

 

STOCKHOLDERS' EQUITY:

 

 

 

 

 

 

Capital stock

 

475,063

 

 

435,495

 

Accumulated deficit

 

(102,509

)

 

(61,270

)

Stockholders' equity attributed to Harvest Health & Recreation Inc.

 

372,554

 

 

374,225

 

Non-controlling interest

 

4,604

 

 

5,572

 

TOTAL STOCKHOLDERS' EQUITY

 

377,158

 

 

379,797

 

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY

$

598,061

 

$

478,599

 

Non-IFRS Financial and Performance Measures

The Company provides additional financial metrics that are not prepared in accordance with IFRS. Management uses non-IFRS financial measures, in addition to IFRS financial measures, to understand and compare operating results across accounting periods, for financial and operational decision making, for planning and forecasting purposes and to evaluate the Company’s financial performance. This non-IFRS financial measure is Adjusted EBITDA.

Management believes that these non-IFRS financial measures reflect the Company’s ongoing business in a manner that allows for meaningful comparisons and analysis of trends in the business, as they facilitate comparing financial results across accounting periods and to those of peer companies. Management also believes that these non-IFRS financial measures enable investors to evaluate the Company’s operating results and future prospects in the same manner as management. These non-IFRS financial measures may also exclude expenses and gains that may be unusual in nature, infrequent or not reflective of the Company’s ongoing operating results.

As there are no standardized methods of calculating these non-IFRS measures, the Company’s methods may differ from those used by others, and accordingly, the use of these measures may not be directly comparable to similarly titled measures used by others. Accordingly, these non-IFRS measures are intended to provide additional information and should not be considered in isolation or as a substitute for measures of performance prepared in accordance with IFRS.

Reconciliations of Non-IFRS Financial and Performance Measures

The table below reconciles Net (Loss) Income to Adjusted EBITDA for the periods indicated.

 

Three months ended June 30,

 

Six months ended June 30,

 

 

2019

 

2018

 

2019

 

2018

 

Net (loss) income (IFRS) before non-controlling interest

$

(21,190

)

$

2,387

 

$

(41,616

)

$

3,198

 

Add (deduct) impact of:

 

 

 

 

 

 

 

 

 

 

 

 

Net interest and other financing costs (1)

 

2,961

 

 

185

 

 

3,736

 

 

305

 

Income tax

 

1,637

 

 

812

 

 

4,035

 

 

1,420

 

Amortization and depreciation (2)

 

2,130

 

 

359

 

 

4,206

 

 

736

 

(Gain)/loss on assets

 

(90

)

 

(1,526

)

 

(90

)

 

(1,526

)

Other income (loss)

 

200

 

 

 

 

249

 

 

 

Foreign currency loss

 

403

 

 

 

 

778

 

 

 

Share-based compensation expense

 

8,094

 

 

 

 

11,397

 

 

 

Other expansion expenses (pre-open)

 

1,365

 

 

 

 

2,495

 

 

 

Transaction & other special charges

 

2,337

 

 

 

 

7,959

 

 

 

Adjusted EBITDA (non-IFRS)

$

(2,153

)

$

2,217

 

$

(6,851

)

$

4,133

 

(1)

   

Includes $190, $-, $520, and $- of interest reported in cost of sales.

(2)

   

Includes $530, $-, $1,113, and $- of depreciation reported in cost of sales.

About Harvest Health & Recreation, Inc.

Headquartered in Tempe, Arizona, Harvest Health & Recreation, Inc. is a multi-state cannabis operator (MSO) and vertically-integrated cannabis company. Subject to completion of announced acquisitions, Harvest will have one of the largest footprints in the U.S., with rights to more than 210 facilities, of which approximately 135 are retail locations, and more than 1,700 employees across 18 states and territories. Since 2011, the company has been committed to expanding its Harvest House of Cannabis retail and wholesale presence throughout the U.S., acquiring, creating and growing leading brands for patients and consumers nationally and continuing on a path of profitable growth. Harvest’s mission is to improve lives through the goodness of cannabis and is focused on its vision to become the most valuable cannabis company in the world. We hope you’ll join us on our journey: https://harvestinc.com.

Facebook: @HarvestHOC
Instagram: @HarvestHOC
Twitter: @HarvestHOC

Forward-looking Statements

This press release contains statements which constitute "forward-looking information" within the meaning of applicable securities laws, including statements regarding the plans, intentions, beliefs and current expectations of Harvest with respect to future business activities. Forward-looking information is often identified by the words "may," "would," "could," "should," "will," "intend," "plan," "anticipate," "believe," "estimate," "expect" or similar expressions and include information regarding: (i) expectations regarding the size of the U.S. cannabis market, (ii) the ability of the Company to successfully achieve its business objectives, (iii) plans for expansion of Harvest, and (iv) expectations for other economic, business, and/or competitive factors.

Investors are cautioned that forward-looking information is not based on historical facts but instead reflects Harvest management's expectations, estimates or projections concerning future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although Harvest believes that the expectations reflected in such forward-looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have material adverse effects on future results, performance or achievements of the combined Company. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information are the following: the ability of Harvest to develop Harvest's brand and meet its growth objectives, the ability of Harvest to complete planned acquisitions that are accretive to it's revenue, the ability of Harvest to obtain and/or maintain licenses to operate in the jurisdictions in which it operates or in which it expects or plans to operate; changes in general economic, business and political conditions, including changes in the financial markets; and in particular the ability of the Company to raise debt and equity capital in the amounts and at the costs that it expects; adverse changes in the public perception of cannabis; decreases in the prevailing prices for cannabis and cannabis products in the markets that the Company operates in; adverse changes in applicable laws; or adverse changes in the application or enforcement of current laws, including those related to taxation; the inability to locate and acquire suitable companies, properties and assets necessary to execute on the Company's business plans; and increasing costs of compliance with extensive government regulation. This forward-looking information may be affected by risks and uncertainties in the business of Harvest and market conditions.

Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although Harvest has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. Harvest does not intend, and does not assume any obligation, to update this forward-looking information except as otherwise required by applicable law.

Additional Information

The financial information reported in this news release is based on unaudited management prepared financial statements for the quarter ended June 30, 2019. Accordingly, such financial information may be subject to change. Financial statements for the period will be released and filed under the Company’s profiles on SEDAR at www.SEDAR.com by August 30, 2019. All financial information contained in this news release is qualified in its entirety with reference to such unaudited financial statements. While the Company does not expect there to be any material changes, to the extent that the financial information contained in this news release is inconsistent with the information contained in the Company’s unaudited financial statements, the financial information contained in this news release shall be deemed to be modified or superseded by the Company’s unaudited financial statements. The making of a modifying or superseding statement shall not be deemed an admission for any purposes that the modified or superseded statement, when made, constituted a misrepresentation for purposes of applicable securities laws.

Media Contact:
Alex Howe, Head of Corporate Communications
ahowe@harvestinc.com

Investor Contact:
Christine Hersey, Director of Investor Relations
chersey@harvestinc.com

NEXT ARTICLE

More From BioPortfolio on "Harvest Health & Recreation, Inc. Reports Second Quarter 2019 Financial Results"

Quick Search

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.